| Identification | Back Directory | [Name]
(S)- 1 -(3,5-Dichloropyridin-4-yl)ethanol | [CAS]
1370347-50-4 | [Synonyms]
EOS-62118 (1S)-1-(3,5-dichloropyridin-4-yl)ethanol (1S)-1-(3,5-Dichloro-4-pyridinyl)ethanol (S)- 1 -(3,5-Dichloropyridin-4-yl)ethanol (S)-1-(3,5-dichloropyridin-4-yl)ethan-1-ol 4-Pyridinemethanol, 3,5-dichloro-α-methyl-, (αS)- (alphaS)-3,5-Dichloro-alpha-methyl-4-pyridinemethanol | [Molecular Formula]
C7H7Cl2NO | [MOL File]
1370347-50-4.mol | [Molecular Weight]
192.04 |
| Chemical Properties | Back Directory | [Boiling point ]
276.1±35.0 °C(Predicted) | [density ]
1.395±0.06 g/cm3(Predicted) | [storage temp. ]
under inert gas (nitrogen or Argon) at 2-8°C | [pka]
12.16±0.20(Predicted) | [Appearance]
White to light yellow Solid | [InChI]
InChI=1/C7H7Cl2NO/c1-4(11)7-5(8)2-10-3-6(7)9/h2-4,11H,1H3/t4-/s3 | [InChIKey]
KCPDCYCCMCEYQN-UFLUHPNLNA-N | [SMILES]
[C@@H](O)(C1C(Cl)=CN=CC=1Cl)C |&1:0,r| |
| Hazard Information | Back Directory | [Uses]
(S)-1-(3,5-Dichloropyridin-4-yl)ethanol is used to prepare (R)-(E)-2-(4-(2-(5-(1-(3,5-dichloropyridin-4-yl)ethoxy)-1H-indazol-3-yl)vinyl)-1H-pyrazol-1-yl)ethanol useful in the treatment of cancer. | [Synthesis]
General procedure for the synthesis of (S)-1-(3,5-dichloropyridin-4-yl)ethanol from 1-(3,5-dichloropyridin-4-yl)ethanol: Firstly, chiral separation of the mixture of stereoisomers was carried out by a CHIRALPAK? AD-H column with 90% heptane/10% ethanol as eluent. The second elution peak, the target enantiomer (S)-1-(3,5-dichloropyridin-4-yl)ethanol, was collected. To determine the absolute configuration of the product, the sample was dissolved in CDCl3 (final concentration 100 mg/mL) and vibrational circular dichroism (VCD) and infrared (IR) spectra were acquired using a ChiralIR FT VCD spectrometer equipped with a BaF2 window and a 100-mm path-length IR unit (BioTools Inc.), with a resolution of 4 cm-1 . using a 150 μL of sample and an acquisition time of 6 h. The data were collected using a VCD spectrometer (BioTools Inc.). Data were presented directly without smoothing or other post-processing. The lowest energy conformation was optimized at the B3PW91/6-31G** level of theory by Gaussian software on a Linux cluster, vibrational frequencies, absorption intensities and VCD intensities were calculated, and vibrational circular dichroism spectra were simulated with a 6 cm-1 Lorentz bandwidth. The analytical results confirm that the product is in S-configuration. Yield: 84.37 g (27% yield). Mass spectrum (electrospray ionization) m/z 192 [M-H]+. | [References]
[1] Patent: WO2010/129509, 2010, A1. Location in patent: Page/Page column 4 [2] Patent: US2012/83511, 2012, A1. Location in patent: Page/Page column 2 [3] Journal of Medicinal Chemistry, 2016, vol. 59, # 14, p. 6690 - 6708 [4] Journal of Medicinal Chemistry, 2016, vol. 59, # 14, p. 6690 - 6708 [5] Patent: CN103819396, 2016, B |
|
| Company Name: |
Energy Chemical
|
| Tel: |
021-021-58432009 400-005-6266 |
| Website: |
http://www.energy-chemical.com |
|